Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Maida Anthony e III, Directeur Clinique. Insider active across 1 company, notably Oncotelic Therapeutics, Inc.. In total, 1 disclosures have been logged. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Anthony E. Maida III is the Chief Clinical Officer at Oncotelic Therapeutics, Inc. In this role, he oversees the company's clinical initiatives, focusing on the development of innovative treatments. Maida is responsible for clinical direction and strategy formulation for clinical trials. His expertise in the healthcare field is essential for the success of Oncotelic Therapeutics.